(3aR,4S,6R,6aS)-2-(6-{7-[(1R,2S)-2-(3,4-Difluoro-phenyl)-cyclopropylamino]-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl}-2,2-dimethyltetrahydro-cyclopenta[1,3]dioxol-4-yloxy)-ethanol 99%

Avra Laboratories Private Limited is amongst the first companies in India to focus onProviding high-end contract research Custom synthesis of complex chemicals
►Manufacturing of niche intermediates and APIs covering various therapeutic areas
including oncology
►Its subsidiary – Avra Synthesis Private Limited is engaged in providing high quality, pre-tested
laboratory chemicals and reagents to various research organizations, companies and academic
institutions
►Has 4 R&D and manufacturing facilities (including one facility owned by Avra Synthesis) located
in Hyderabad and Visakhapatnam in India
►Facilities are certified with ISO 9001 and the company follows cGLP and cGMP practices
►USFDA approved facility
►The company has been profitable since its first year of operations

Avra’s vision is to become a global research organization with core competencies in chemistry and to be recognized as a reliable long term partner by global pharmaceutical companies
Avra’s aim is to become a one-step destination for international pharmaceutical companies that require chemistry based support starting from lead generation till commercial production of APIs and intermediates.